Accenture partners with nearly a dozen health care firms to determine RFID's true value.
Is all the RFID noise giving you a headache? Take two aspirin and call Accenture Ltd. in the morning.
The management consulting firm has organized a group of pharmaceutical manufacturers, distributors and retailers to explore radio frequency identifications (RFIDs) true ability to:
enhance the safety and security of the pharmaceutical supply chain;
improve the process of pharmaceutical returns management; and
* increase the efficiency of distribution operations.
Key project partners include Abbott Laboratories, Barr Pharmaceuticals, Cardinal Health, CVS Pharmacy, Johnson & Johnson, McKesson, Pfizer, Procter & Gamble, Rite Aid, Healthcare Distribution Management Association (HDMA) and National Association of Chain Drug Stores (NACDS). The group plans to test how RFID technology can improve:
expiration date management;
lot and batch tracking;
returns management processing;
shipping and receiving accuracy;
and product security and consumer safety, among other areas.
Separately, Sun Microsystems Inc. and SupplyScape have launched an "anti-counterfeiting" RFID package that protects pharmaceuticals as they move through the supply chain.
These developments sound promising, but I suspect RFID is still 12 to 18 months away from wide scale deployment at most companies. (Read why in my recent RFID feature in eWeek).
For the full article click here.
Check out eWEEK.coms Mobile & Wireless Center at http://wireless.eweek.com for the latest news, views and analysis on wireless communication.
Be sure to add our eWEEK.com Mobile & Wireless feed to your RSS newsreader: